Bong originally joined Venrock in 2009 and has been doing public and private investing since 2004. He did his medical training at Harvard’s Mass Eye & Ear Infirmary (ophthalmology), Stanford Hospital (internal medicine) and UCSF (pathology).
Bong focuses on Venrock’s public and cross-over biotech fund, Venrock Healthcare Capital Partners, where he provides leadership in biotech investments. Bong is on the AveXis’ board of directors.
Bong earned his B.A. from Yale University, his M.D. from the University of California, San Francisco, and an M.B.A. from Harvard Business School.